EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a regular round up of news relevant to hospital pharmacy in Europe.
In 40 days, the European Association of Hospital Pharmacists (EAHP) will be hosting the largest gathering of hospital pharmacists in Europe. Join professionals from all around the globe from 22 to 24 March in Lisbon, Portugal for EAHP’s 27th Congress focused on “From drug design to treatment success – What really matters to patients?”.
This year’s Synergy Satellite Event (sponsored by an educational grant from CSL Vifor) will be focused on “Non-Biologic Complex Drugs (and nano medicines)”. Non-Biological Complex Drugs (NBCDs) are drugs that comprise large high molecular weight molecules and, often, nanoparticles structures. In this category we currently include glatiramoids, iron oxide carbohydrate nanoparticles, liposomes, and polymeric micelles. Those participating in the Synergy Satellite Event will be able to explain their newly acquired understanding of NBCDs, describe how pharmacists must be involved in NBCD evaluation, understand the different approvals pathways of NBCD and list examples of NBCDs. Those interested in learning more about NBCDs can join the Synergy Satellite Event on 22 March from 17.15 to 18.45.
Two of EAHP’s Special Interest Groups (SIGs) will share the results of their work on 22 March between 10.30 and 12.00. The presentation titled “The EAHP roadmap toward eliminating avoidable harm” will elucidate root causes and recommend measures reducing avoidable harm within the supply, preparation and safe administration of medicines in European hospitals. During the second presentation “Investigation of Medication Errors in Intensive Care Units” participants will be familiarised with the policy recommendations that the SIG develop to enhance medication safety which may contribute to reducing medication errors in ICUs across Europe.
Register for EAHP’s 27th Congress HERE
Follow us on Twitter, Facebook, Instagram, and LinkedIn to stay up-to-date with the latest news from #EAHP2023
On 13 December 2022, the European Commission organised a multistakeholder event focused on biosimilar medicines. Different stakeholders contributed, including EAHP’s Director of Professional Development Despoina Makridaki.
The event focused on biosimilar competition, interchangeability, switching and substitution of biosimilars and national biosimilar policies. In addition, oncology biosimilars and trust in them were explored further. The event was concluded by a panel discussion to which patients, healthcare professionals, payers and industry representatives contributed. In case you missed the event, you can access all presentations as well as the recording online.
Access the presentations and recording HERE
In mid-January, close to a hundred experts from across Europe gathered to discuss European and national vaccination policies and healthcare professionals’ role in increasing vaccine confidence and uptake. EAHP was represented at the Coalition for Vaccination conference by its Director of Finance Nenad Miljković.
The event followed the adoption of Council Conclusions in December 2022 which reaffirmed that vaccination is one of the most effective tools in the prevention of infectious diseases, highlighted the importance of communication training for healthcare professionals and reinforced the role of the Coalition. Those participating in the conference reiterated the need for all actors to work together to close vaccination gaps.
With its deliverables in the finalisation stage, the IMMUNION project presented its work during the conference. The aim of the project that was set up in 2021 was to strengthen collaboration between healthcare professionals and other stakeholders, addressing issues of access to accurate, evidence-based information about vaccination. This was primarily achieved through strategies focused on communication and training. In addition, tools and resources were developed to increase vaccine coverage, in particular amongst underserved populations.
Learn more about the IMMUNION project HERE
Learn more about the Coalition for Vaccination HERE
Leading up to World Cancer Day – which took place on 4 February – the Organisation for Economic Co-operation and Development (OECD) present the first Country Cancer Profiles under the European Cancer Inequalities Registry.
The European Cancer Inequalities Registry is a flagship initiative of Europe’s Beating Cancer Plan. It provides sound and reliable data on cancer prevention and care to identify trends, disparities and inequalities between Member States and regions. The profiles highlighted that cancer is the second cause of mortality in the EU after circulatory diseases, that there are wide disparities in cancer mortality across countries and gender and that the challenges to provide high quality care differ. While some countries are well equipped, but face shortages in qualified health care staff, others have a high number of qualified physicians, but lack, for example, radiation therapy equipment.
Access the Country Cancer Profiles HERE
Since the beginning of February, the additional responsibilities regarding the monitoring and mitigation of shortages of critical medical devices during public health emergencies of the European Medicines Agency (EMA) are applicable. The Agency is now responsible for coordinating responses of EU / EEA countries to shortages of critical medicines and medical devices including in-vitro diagnostics during public health emergencies.
The work of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – which was set up almost a year ago – will from now be complemented by the Medical Devices Shortages Steering Group (MDSSG). The MDSSG is tasked with coordinating urgent actions within the Union in relation to the management of supply and demand issues of critical medical devices and making recommendations to relevant stakeholders, including the European Commission, Member States and notified bodies.
The MDSSG will be composed of a representative of the Agency, a representative of the European Commission and one representative appointed by each Member State. The MDSSG will be co-chaired by the Agency and by a representative of a Member State. A representative of the Agency’s Patients’ and Consumers’ Working Party (‘PCWP’) and Healthcare Professionals’ Working Party (‘HCPWP’) may attend meetings of the MDSSG as observers.
Learn more about the work of the MDSSG HERE
Learn more about the work of the MSSG HERE
The online first edition of the European Journal of Hospital Pharmacy (EJHP) recently published research outlining how EU/European Economic Area (EEA) national competent authorities have implemented the recommendations of the good practice guidance. Results showed that since the publication of the EMA/HMA good practice guide in 2019, transparency has increased across the EU/EEA, and public catalogues of shortages are now a routine tool used by many medicines agencies. Further opportunities to improve transparency on supply issues lie ahead with the EMA network strategy to 2025, the revised EU pharmaceutical legislation and the new legal mandate reinforcing the role of the EMA.
Read the full article HERE
Drug Information Centre Survey
The University Hospitals of Leuven (UZ Leuven) is developing a drug information centre (DIC) to expand their current services. A DIC is defined as a centre that provides technical and scientific information about drugs in an objective and timely manner to ensure the safe and effective use of therapeutic and diagnostic pharmaceuticals. To support the development of the DIC in UZ Leuven a survey has been designed aiming to collect information about the operations, service characteristics and governance of DIC’s already operating in Europe. This survey will take approximately 3-20 minutes to complete depending on the path which is followed.
Contribute to the survey via the following LINK
Bedside clinical pharmacists in Europe
In this research, organized by the Semmelweis University, Hungary the position of bedside clinical pharmacists in hospitals will be assessed to gain insight into the routine practices and the provided clinical pharmacy services. The researchers would like to hear your opinion based on your experiences, so there are no correct or incorrect answers. It takes about 15 minutes to complete the questionnaire.
Contribute to the survey via the following LINK
SUPPLY – Immunoglobulin shortages survey
The SUPPLY project would like to gain your insights into the situation of immunoglobulin (Ig) shortages and the decision-making process regarding it within hospitals. The survey will take approximately 20 minutes to complete.
Contribute to the survey via the following LINK
European Paediatric Formulary: Chloral Hydrate Oral Solution monograph
The European Directorate for the Quality of Medicines & HealthCare (EDQM) released Issue 5 of Pharmeuropa PaedForm, in which the draft text for Chloral hydrate 100 mg/mL Oral Solution is published for public consultation prior to its inclusion in the European Paediatric Formulary. The deadline for comments on the text in Pharmeuropa PaedForm is 31 March 2023. This is the sixth monograph elaborated on by the PaedF Working Party. The EDQM welcomes all comments on this new monograph from users and interested parties.
Learn more about this consultation HERE
